ヘパリスファーマ株式会社

Tokyo, JP · 2 known investors

Hepalys Pharma is a late-stage biopharmaceutical company developing innovative therapeutics for liver disease in Japanese and Asian patients, focusing on metabolic dysfunction-associated steatohepatitis (MASH) treatment through its lead candidate Lanifibranor.

BiotechMedical Devices